| EPF wishes to thank the following sponsors for their support in the form of unrestricted grants to EPF'S | 
| operational programme 2011 : |  |  |  | 
|  |  |  | % of total income | 
| AMGEN | € 25,000.00 |  | 3.2% | 
| AztraZeneca (1) | € 50,000.00 |  | 6.3% | 
| Baxter | € 10,000.00 |  | 1.3% | 
| CSL Behring | € 10,000.00 |  | 1.3% | 
| GILEAD (2) | € 15,000.00 |  | 1.9% | 
| GSK (3) | € 41,932.89 |  | 5.3% | 
| Janssen Pharmaceutica | € 10,000.00 |  | 1.3% | 
| Microsoft | € 20,000.00 |  | 2.5% | 
| MSD | € 30,000.00 |  | 3.8% | 
| Novartis | € 50,000.00 |  | 6.3% | 
| Pfizer | € 50,000.00 |  | 6.3% | 
| Philips (4) | € 20,000.00 |  | 2.5% | 
| Phrma | € 40,000.00 |  | 5.1% | 
| Sanofi Aventis | € 25,000.00 |  | 3.2% | 
| Sanofi Pasteur MSD | € 20,000.00 |  | 2.5% | 
| Les Laboratoires Servier | € 10,000.00 |  | 1.3% | 
| Shire | € 5,000.00 |  | 0.6% | 
|  |  |  |  | 
| (1) 2011 contribution received in 2012 |  |  |  | 
| (2) A contribution of € 45,000 was received from GILEAD in 2011 of which € 30,000 related to 2010 and € 15,000 to 2011 | 
| (3) GSK gave honoraria of €1000 and travel of €932,39 to support the attendance of EPF Executive Director at meetings | 
| GSK’s  April and November European Health Advisory Board |  |  |  | 
| (4) 2011 contribution received in 2010 |  |  |  | 
|  |  |  |  | 
| EPF wishes to thank the following sponsors for their support in the form of unrestricted grants to EPF'S | 
| events in 2011 : |  |  |  | 
| Annual General Meeting |  |  |  | 
| Eli Lilly | € 20,000.00 |  | 2.5% | 
| Hoffmann La Roche | € 20,000.00 |  | 2.5% | 
| Janssen Pharmaceutica | € 20,000.00 |  | 2.5% | 
|  |  |  |  | 
| Regional Advocacy Seminar |  |  |  | 
| Medtronic Foundation | € 30,000.00 |  | 3.8% | 
| SANOFI AVENTIS | € 15,000.00 |  | 1.9% | 
|  |  |  |  | 
| Conference on Rights and Needs of Older Patients |  |  |  | 
| AMGEN | € 10,000.00 |  | 1.3% | 
| GSK * | € 30,000.00 |  | 3.8% | 
| Novartis | € 30,000.00 |  | 3.8% | 
| Pfizer | € 30,000.00 |  | 3.8% | 
| * 2011 Contribution paid in 2010 |  |  |  | 
|  |  |  |  | 
| EPF wishes to thank the European Commission for its support in 2011 |  |  |  | 
| in relation to Epf's role in the following projects : |  |  |  | 
| Respect * | € 16,311.00 |  | 2.1% | 
| Renewing Health * | € 27,163.92 |  | 3.4% | 
| Interquality | € 48,094.00 |  | 6.1% | 
| Chain of Trust | € 41,376.65 |  | 5.2% | 
| E-Health Governance | € 4,500.00 |  | 0.6% | 
| * 2011 contribution to be received in 2012 |  |  |  | 
|  |  |  |  |